Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001213900-25-111299
Filing Date
2025-11-17
Accepted
2025-11-17 08:51:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 FOR REGISTRATION OF CERTAIN CLASSES ea0265959-8a12b_oramed.htm 8-A12B 28291
2 RIGHTS AGREEMENT, DATED AS OF NOVEMBER 17, 2025, BETWEEN ORAMED PHARMACEUTICALS ea026595902ex1_oramed.htm EX-1 242441
3 PRESS RELEASE, DATED NOVEMBER 17, 2025 ea026595902ex2_oramed.htm EX-2 9031
  Complete submission text file 0001213900-25-111299.txt   280998
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-35813 | Film No.: 251489483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)